Exhibit 99.1 RingCentral Announces Fourth Quarter and Fiscal Year 2025 Results Total revenue at $2.5 billion, up 5% Operating cash flow of $617 million, up 28% YoY; free cash flow of $530 million, up 32% YoY Initiates quarterly cash dividend of $0.075 per share Increases share repurchase authorization to $500 million "Our 2025 results reflect disciplined execution across growth, profitability, and capital allocation. We expanded GAAP operating margin to 4.8% and non-GAAP operating margin to 22.5%, generated ...

Hospital Operations - As of December 31, 2025, the company operated 104 critical illness recovery hospitals across 28 states, with approximately 37%, 33%, and 32% of revenue from Medicare reimbursement for the years ended December 31, 2023, 2024, and 2025, respectively [22]. - The company operated 1,917 outpatient rehabilitation clinics across 39 states and the District of Columbia as of December 31, 2025 [51]. - The company has a significant presence in the rehabilitation hospital segment, operating 38 rehabilitation hospitals in 15 states as of December 31, 2025 [63]. - As of December 31, 2025, the company operated 104 critical illness recovery hospitals and 38 rehabilitation hospitals, all certified by Medicare [100]. - The company operated 18 critical illness recovery hospitals and 11 rehabilitation hospitals that are treated as provider-based satellites, with 294 outpatient rehabilitation clinics also classified as provider-based [163]. Patient Care and Quality - The average length of stay for patients in critical illness recovery hospitals was 31 days for the year ended December 31, 2025 [24]. - The average length of stay for patients in rehabilitation hospitals was 14 days for the year ended December 31, 2025 [38]. - All rehabilitation hospitals were accredited by TJC and certified by Medicare as inpatient rehabilitation facilities as of December 31, 2025 [39]. - The company focuses on high-quality care and service, utilizing patient satisfaction surveys to continuously improve service levels [55]. - The company maintains quality assurance programs to support and monitor care standards, ensuring compliance with regulatory requirements and Medicare certifications [31]. Financial Performance - Medicare accounted for 28.6% of the company's revenue in 2025, while commercial insurance represented 51.6% [71]. - Revenue from workers' compensation programs accounted for approximately 15% of outpatient rehabilitation segment revenue, 2% of rehabilitation hospital segment revenue, and 1% of critical illness recovery hospital segment revenue for the year ended December 31, 2025 [102]. - The company's revenue sources include Medicare and Medicaid, which generally pay less than customary charges for services provided [73]. - The company employed approximately 45,300 employees, including 30,800 full-time and 14,500 part-time employees [75]. - The company has approximately 17,500 credentialed practitioners providing services in its hospitals [78]. Strategic Growth - The company is pursuing opportunistic acquisitions to grow its network of critical illness recovery hospitals, focusing on improving financial performance through clinical program additions and centralized administrative functions [36]. - The company aims to increase commercial volume by expanding relationships with commercial insurers, offering high-quality, cost-effective care [35]. - The company aims to increase market share by opening new clinics in existing markets and entering joint ventures with hospital systems [56]. - The company is pursuing opportunistic acquisitions to grow its network of rehabilitation facilities and improve financial performance [60]. Regulatory Compliance - The company is required to comply with the Health Insurance Portability and Accountability Act (HIPAA) and has a Privacy and Security Committee to monitor compliance, which has not materially affected its financial condition [169]. - The company must provide clear pricing information online for at least 300 "shoppable services" as mandated by new regulations effective January 1, 2021 [174]. - The Stark Law imposes penalties for prohibited referrals, including civil monetary penalties of up to $15,000 per service and exclusion from federal healthcare programs [162]. - The company is required to monitor government publications to enhance compliance efforts related to fraud and abuse enforcement [159]. - The Compliance and Audit Committee meets quarterly to review compliance program activities and ensure adherence to regulatory requirements [182]. Operational Challenges - The company faces significant operating issues due to shortages of clinical personnel, which may lead to increased use of costly temporary labor [76]. - The company has implemented a communications tool called the "10-Foot Circle of Employee Safety," resulting in significant reductions in workplace injuries [87]. - The company maintains strong community and employee relations, emphasizing quality care and customer service to drive patient volume [59]. Financial Obligations - As of December 31, 2025, Select had outstanding borrowings of $1,039.5 million under a term loan and $100.0 million under a revolving facility, with variable interest rates [444]. - An interest rate cap was entered into on March 31, 2025, limiting the Term SOFR rate to 4.5% on $1.0 billion of principal outstanding under the term loan, applicable through March 31, 2028 [445]. - A 0.25% increase in market interest rates will impact the annual interest expense on variable rate debt by $2.8 million per year [446].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________ FORM 10-K ____________________________________ ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2025 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 001-36257 TRAVERE THERAPEUTICS, INC. (Exact Name of Registrant as specified in its Charter) Delaware 27-484269 ...

Exhibit 99.1 Century Aluminum Company Reports Fourth Quarter 2025 Results Chicago, February 19, 2026 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its fourth quarter and full year 2025 results. Fourth Quarter 2025 Highlights Full Year 2025 Highlights Fourth Quarter & Full Year 2025 Financial Results | $MM (except shipments and per share data) | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | | | Q4 2025 | Q3 2025 | | FY 2025 | FY 2024 | | Shipments (tonnes) | | 140,25 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-09447 KAISER ALUMINUM CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3030279 (State or other jurisdiction of incorpo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________ Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-32601 LIVE NATION ENTERTAINMENT, INC. (Exact name of registrant as specified in its charter) Delawar ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-37983 TechnipFMC plc (Exact name of registrant as specified in its charter) United Kingdom 98-1283037 (State or other jurisdiction of incorporat ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2025 Commission File Number 1-11758 (Exact name of Registrant as specified in its charter) | Delaware 1585 Broadway | | 36-3145972 | (212) 761-4000 | | --- | --- | --- | --- | | (State or other jurisdiction of | New York, NY 10036 | (I.R.S. Employer Identification No.) | (Registrant's telephone ...

Exhibit 99.1 FOR IMMEDIATE RELEASE 4714 Gettysburg Road Mechanicsburg, PA 17055 NYSE Symbol: SEM Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2025, Its 2026 Business Outlook, and Cash Dividend MECHANICSBURG, PENNSYLVANIA — February 19, 2026 — Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its fourth quarter and year ended December 31, 2025, its 2026 business outlook, and the decl ...

Media Relations Consolidated Edison, Inc. New York, NY 10003 www.conEdison.com Exhibit 99.1 212 460 4111 (24 hours) 4 Irving Place FOR IMMEDIATE RELEASE Contact: Allan Drury February 19, 2026 212-460-4111 CON EDISON REPORTS 2025 EARNINGS NEW YORK - Consolidated Edison, Inc. (Con Edison) (NYSE: ED) today reported 2025 net income for common stock of $2,023 million or $5.66 a share compared with $1,820 million or $5.26 a share in 2024. Adjusted earnings (non- GAAP) were $2,038 million or $5.70 a share in 2025 ...